Determination of tramadol, metamizole, ropivacaine, and bupivacaine in analgesic mixture samples by HPLC with DAD detection

Journal of Chromatographic Science

Volumn 47, Issue 3, 2009, Pages 231-237

  Salmeron Gacia A ^a   Navas, N ^b   Martin, A ^b   Roman, E ^a   Cabeza, J ^a   Capitan Vallvey L F ^b  

^a HOSPITAL UNIVERSITARIO SAN CECILIO   (Spain)

^b UNIVERSITY OF GRANADA   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

BOVINE PARVOVIRUS; REINDEER PAPILLOMAVIRUS;

AMIDE; ANALGESIC AGENT; BUPIVACAINE; DIPYRONE; LOCAL ANESTHETIC AGENT; NARCOTIC ANALGESIC AGENT; NONSTEROID ANTIINFLAMMATORY AGENT; ROPIVACAINE; TRAMADOL;

ARTICLE; DRUG STABILITY; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HYDROLYSIS; METHODOLOGY; QUALITY CONTROL; REPRODUCIBILITY; SENSITIVITY AND SPECIFICITY;

AMIDES; ANALGESICS; ANALGESICS, OPIOID; ANESTHETICS, LOCAL; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; BUPIVACAINE; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; DIPYRONE; DRUG STABILITY; HYDROLYSIS; QUALITY CONTROL; REPRODUCIBILITY OF RESULTS; SENSITIVITY AND SPECIFICITY; TRAMADOL;

EID: 65449150534     PISSN: 00219665     EISSN: None     Source Type: Journal    
DOI: 10.1093/chromsci/47.3.231     Document Type: Article

References (35)

1. E. Welchew. Patient Controlled Analgesia. Blackwell BMJ Books, Malden, MA, 1995.
2. V. Thomas, M. Heath, D. Rose, and P. Flory. Psychological characteristics and the effectiveness of patient-controlled analgesia. Brit. J.Anaesth. 74:271-76(1995).
3. G. Bernatzky and I. Jurna. Intrathecal injection of codeine, buprenorphine, tildine, tramadol, and nefopam depresses the tail-flick response in rats. Eur.J. Pharmacol. 120: 75-83 (1986).
4. P. Schonhofer, L. Offerhaus, and A. Herxheimer. Dipyrone and agranulocytosis: what is the risk? Lancet 360: 968-69 (2003).
5. F. Arellano and J.A. Sacristán. Metamizole: reassessment of its therapeutic role. Eu. J. Clin. Pharmacol. 38: 617-19 (1990).
6. K. Hedenmalm and O. Spigset. Agranulocytosis and other blood dyscrasias associated with dipyrone (metamizole). Eur. J. Clin. Pharmacol. 58: 265-74 (2002).
7. J.C. Wessel, M. M. Matyja, M. Neugebauer, H. Kiefer, T. Daldrup, F.A. Tarbah, and H. Weber, Characterization of oxalic acid derivatives as new metabolites of metamizol (dypirone) in incubated hen's egg and human. Eur. J. Pharmac. Sci. 28:15-25 (2006).
8. E. Zylber-Katz, L. Granit, and M. Levy. Formation and excretion of dipyrone metabolites in man. Eur. J. Clin. Pharmacol. 42:187-91 (1992).
9. G. Geisslinger, R. Boeker, and M. Levy. High-performance liquid Chromatographie analysis of dipyrone metabolites to study their ormation in human liver microsomes. Pharmaceut. Res. 13:1272-75 (1996).
10. H. Ergun, D.A.C. Frattarelli, and J.V. Aranda. Characterization of the role of physicochemical factors on the hydrolysis of dipyrone. J. Pharm. Biomed. Sci. 35:479-87 (2004).
11. P. Rohdewald, G. Drehsen, E. Milsmann, and H. Derendorf. Arzneimittelforschung 33: 985-88 (1983).
12. A.A. Campanero, E. García-Quetglas, B. Sádaba, and J.R. Azanza. Simultaneous stereoselective analysis of tramadol and its primary phase I metabolites in plasma by liquid chromatography: Application to a pharmacokinetic study in humans. J. Chromatogr. A 1031: 219-28(2004).
13. M.R. Rouini, Y.H. Ardakani, F. Soltani, H.Y. Aboul-Enein, and A. Foroumadi. Development and validation of a rapid HPLC method for simultaneous determination of tramadol, and its two main metabolites in human plasma. J. Chromatogr. B 830:207-11 (2006).
14. M. Zecevic, Z. Stankovic, L.J. Zivanovic, and B. Jocic. Validation of a high-performance liquid Chromatographie method for the simultaneous determination of tramadol and its impurities in oral drops as a pharmaceutical formulation, J. Chromatogr. A 1119: 251-56 (2006).
15. V. Kmetec and R. Rostar. HPLC determination of tramadol in human breast milk. J. Pharm. Biomed. Anal. 32:1061-66 (2003).
16. G. Parhizkari, G. Delker, R.B. Miller, and C. Chen. A stability-indicating HPLC method for the determination of benzalkonium chloride in 0.5% tramadol ophthalmic solution. Chromatographia 40: 155-58(1995).
17. H.Z. Senyuva, I. Aksahin, S. Ozcan, and B.V. Kabasakal. Rapid, simple and accurate liquid chromatography-diode array detection validated method for the determination of dipyrone in solid and liquid dosage forms. Anal. Chim. Acta 547: 73-77 (2005).
18. I. Baranowska, P. Markowski, and J. Baranowski. Simultaneous determination of 11 drugs belonging to four different groups in human urine samples by reversed-phase high-performance liquid chromatography method. Anal. Chim. Acta 570: 46-58 (2006).
19. G.B. Golubitskii, E.V. Budko, and V.M. Ivanov. Quantitative analysis of pentalgin N tablets by gradient and isocratic high-performance liquid chromatography.). Anal. Chem. 61: 74-79 (2006).
20. G.B. Golubitskii, E.V. Budko, E.M. Basova, and V.M. Ivanov. Kinetic-Chromatographic determination of 4-methylaminoan-tipyrine in Pentalgin N and Pentalgin FS tablets. J. Anal. Chem. 62: 658-64 (2007).
21. J. Drewe, S. Rufer, J. Huwyler, and E. Küsters. High-performance liquid Chromatographie method for an automated determination of local anaesthetics in human plasma. J. Chromatogr. B 691:105-10 (1997).
22. H. Lotfi, J. Debord, M.F. Deryfuss, P. Marquet, M.B. Feiss, and G. Lachatre. Simultaneous determination of lidocaine and bupivα-caine in human plasma: application to pharmacokinetics. Ther DrugMonit. 19:160-64 (1997).
23. X.Q. Gu, B. Fryirs, and L.E. Mather. High-performance liquid Chromatographie separation and nanogram quantitation of bupivα-caine enantiomers in blood. J. Chromatogr. B 719:135-40 (1998).
24. M. Zuo, G. Duan, and Z. Ge. Simultaneous determination of ropi-vacaine and antipyrine by high performance liquid chromatography an dits application to the in vitro transplacental study. Biomed. Chromtogr. 18: 752-55 (2004).
25. S. Reif, P. Corre, G. Dollo, F. Chevanne, and R. Verge. High-performance liquid Chromatographie determination of ropivacaine, 3-hydroxy-ropivacaine, 4-hydroxy-ropivacaine and 2',6'-pipe-coloxylidide in plasma. J. Chromatogr. B 719: 239-44 (1998).
26. J.A. Jonsson, M. Anderson, C. Melander, J. Norberg, E. Thordrson, and L. Mathiasson. Automated liquid membrane extraction for high-performance liquid chromatography of ropivacaine metabolites in urine. J. Chromatogr. A 870:151-57 (2000).
27. K.O. Svedberg, E. Chem, J. McKenziet, and C. Larrivee-Elkinsl. Compatibility of ropivacaina with morphine, sufentanil, fentanyl, or clonidine. J. Clin. Pharm. Ther. 27: 39-45 (2002).
28. M.J. Sánchez-del Aguila, M.F. Jones, and A. Vohra. Premixed solutions of diamorphine in ropivacaine for epidural anaesthesia: a study on their long-term stability. Brit. J. Anaesth. 90:179-82 (2003).
29. G. Brodner, N. Mertes, H. Aken, T. Molhoff, M. Zahl, S. Wirtz, M. Marcus, and H. Buerkle. What concentration of sufentanil should be combined with ropivacaine 0.2% wt/vol for postoperative patient controlled epidural analgesia? Aesth. Analg. 90: 649-57 (2000).
30. A.R. Barnes and S. Nash. Stability of bupivacaine hydrochloride with diamorphine hydrochloride in an epidural infusion. Pharm. World Sci. 17: 87-92 (1995).
31. N. Rifai, O. Hsin, T. Hope, and M. Sakamoto. Simultaneous measurements of plasma ropivacaine and bupivacaine by HPLC with UV detection. Ther. Drug Monit. 23:182-86 (2001).
32. T. Arvidsson and E. Aklund. Determination of free concentration of ropivacaine and bupivacaine in blood plasma by ultrafiltration and coupled column liquid chromatography. J. Chromatogr. B 668: 91-98(1995).
33. Analytical Methods Committee. It is my calibration linear? Analyst 119:2363-66 (1994).
34. M. Levy, E. Zylber-Katz, and B. Rosenkranz. Clinical pharmacokinetics of dipyrone and its metabolites. Clin. Pharmcokinet. 28: 216-34(1995).
35. N.P. Kovalenko, Y.A. Ershov, and S.F. Orlova. Kinetics of photochemical rearrangements and spectral behaviour of pyrazolone derivatives in solution. J. Photochem. 31: 289-96 (1985).